Clinical

Dataset Information

0

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer


ABSTRACT: This phase II trial studies how well savolitinib works in treating patients with MET amplified colorectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). Savolitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

DISEASE(S): Adenocarcinoma,Stage Ivb Rectal Cancer Ajcc V8,Stage Iiib Colon Cancer Ajcc V8,Stage Iv Rectal Cancer Ajcc V8,Stage Iiic Rectal Cancer Ajcc V8,Stage Iii Colon Cancer Ajcc V8,Metastatic Colon Adenocarcinoma,Stage Ivc Rectal Cancer Ajcc V8,Colorectal Carcinoma,Stage Iv Colon Cancer Ajcc V8,Stage Iiib Rectal Cancer Ajcc V8,Stage Iiia Colon Cancer Ajcc V8,Unresectable Colon Adenocarcinoma,Colorectal Neoplasms,Stage Iva Colon Cancer Ajcc V8,Stage Ivc Colon Cancer Ajcc V8,Stage Iiic Colon Cancer Ajcc V8,Metastatic Rectal Adenocarcinoma,Stage Iiia Rectal Cancer Ajcc V8,Stage Ivb Colon Cancer Ajcc V8,Unresectable Rectal Adenocarcinoma,Stage Iva Rectal Cancer Ajcc V8,Rectal Neoplasms,Stage Iii Rectal Cancer Ajcc V8,Colonic Neoplasms

PROVIDER: 2278111 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2182409 | ecrin-mdr-crc
| 2301091 | ecrin-mdr-crc
| 2201648 | ecrin-mdr-crc
| 2140889 | ecrin-mdr-crc
| phs001570 | dbGaP
| 2050120 | ecrin-mdr-crc
| 2316804 | ecrin-mdr-crc
2021-11-23 | GSE189461 | GEO
2016-05-13 | E-GEOD-77320 | biostudies-arrayexpress
2017-05-01 | GSE94405 | GEO